EMUC15: Best unmoderated posters in bladder and kidney cancers

The 7th EMUC has awarded today the three best unmoderated abstract posters to researchers from Italy, Israel and Belgium. Session chairpersons Profs. Bertrand Tombal and Harriet Thoeny cited the innovative approaches and insights on managing bladder and kidney cancers. Below is the list of winners:

First PrizeNecchi, A, et al., "Neoadjuvant sorafenib, gemcitabine and cisplatin (SCC) for muscle-invasive urothelial bladder cancer (UBC): Updated clinical and transitional findings of an open-label, single group, phase 2 study" (Italy)

Second PrizeKeizman, D. et al., "Metformin (met) use and outcome of sunitinib (Su) treatment (tx) in diabetic patients (pts) with metastatic renal cell carcinoma (mRCC);" (Israel)

Third PrizeElsen, S. et al., "Evans blue as a diagnostic tool for non-muscle invasive bladder cancer." (Belgium)